Synergy Pharma Reports Long-Term Data On Plecanatide In Chronic Idiopathic Constipatio

By: via Benzinga
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) presented long-term data on safety of plecanatide. The FDA is currently assessing the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.